April 10 – 12, 2019 – Oxon Hill, MD
The World Orphan Drug Congress will gather in Maryland in April 2019 to bring together industry leaders from all reaches of the BioPharma and Biotechnology industry to share information and ideas on this important topic.
According to the organizers “World Orphan Drug Congress USA focuses on the most pressing challenges and opportunities to bring rare disease therapies to patients faster. Bringing together a global gathering of 1,200 leaders in orphan drugs from 50 countries, World Orphan Drug Congress USA will feature over 135 presentations covering all aspects of orphan drug development and rare disease research.
The World Orphan Drug Congress USA has always remained up to date with the evolving rare disease landscape to become the largest and most global annual gathering of orphan drug stakeholders.
We have expanded the program to focus on cell and gene therapies for rare diseases as well as rare oncology. While becoming more comprehensive from a topic area perspective, the World Orphan Drug Congress continues to expand globally, bringing government authorities, payers, industry and patient advocacy groups from over 50 countries.”
